DNA, Blood and Skin Cell Repository for Research on ALS and Related Neurodegenerative Disorders at Mayo Clinic Florida

DNA, Blood and Skin Cell Repository for Research on ALS and Related Neurodegenerative Disorders at Mayo Clinic Florida

Quick Info:

Status:
Currently Recruiting
Estimated Enrollment:
160
Phase:
Treatment Type:
Sample Collection (patient registry)
Trial Type:
Observational
Sponsor:
Mayo Clinic
Primary Investigator:
Contact Information:
  • 904-953-6523

Trial Goal:

Biobanks

Biobanks

PALS tissues help scientists identify potential biomarkers and drugs
Tests to Expect:
Blood Draw

Blood Draw

Skin Biopsy

Skin Biopsy

Update Notes:

6/6/2019No significant updates
3/23/2018Principal investigator updated
3/23/2017No significant updates
1/5/2016No significant updates.
4/15/2015No significant updates.
9/26/2014Contact information updated.
9/17/2014No significant updates.
7/16/2013No significant updates.
1/29/2013Protocol information updated

Locations:

Jacksonville, 32224

Other Information:

Purpose: This study is intended to obtain clinical information and establish a repository of DNA, RNA, peripheral blood monocyte, lymphocyte and skin tissue samples from people with ALS and related neurodegenerative motor neuron diseases, people with a family history of these conditions, and healthy people with no family history of these disorders. The samples will be used in future research to learn about how these disorders affect people, what causes these conditions, and how the investigators can tell when someone has this kind of disease. Future research may also include the generation of stem cells from stored blood cell and skin cell samples. Participants will not be paid for taking part in this study.
Eligibility: 18 years and older. All genders. Accepting healthy volunteers.
Details: Enrolling by invitation. This study will establish a repository of stored DNA, RNA, monocyte, lymphocyte, and skin fibroblast samples from people with ALS and ALS-FTD, subjects with a family history of ALS who do not have ALS or ALS-FTD, and subjects with no personal history of ALS or dementia, to support future translational and basic research studies on ALS and related neurodegenerative disorders.
Collaborator(s):
News Articles and Summaries:
ALS Forum:
First Published on Clinicaltrials.gov: 9/30/2012
ClinicalTrials.gov ID: NCT01699451
Trial Protocol as Published on Clinicaltrials.gov:
ClinicalTrials.gov